Request to Join
has invited you to join this group
Morten Hylander Møller is an intensivist and Associate Professor at the Dept. of Intensive Care, Copenhagen University Hospital Rigshospitalet, Denmark.
His major research interests are clinical research and research methodology, including systematic assessment of the balance between the benefits and harms of commonly used critical care interventions and clinical practice guidelines.
He is actively involved in Centre for Research in Intensive Care (CRIC), Scandinavian Society of Anaesthesiology and Intensive Care Medicine (SSAI) and Guidelines in Intensive Care, Development and Evaluation (GUIDE).
Morten has published more than 100 peer-reviewed publications and he is an editor of Journal of Intensive Care Medicine and Acta Anaesthesiologica Scandinavica.
He is the Sponsor of the Stress Ulcer Prophylaxis in the Intensive Care unit (SUP-ICU) trial.
Morten suffers from the rare and serious critical care condition “severe scepsis” and the cornerstone of his practice is primum non nocere.
Søren Marker MD is a Research Fellow at the Dept. of Intensive Care, Copenhagen University Hospital Rigshospitalet, Denmark.
He is the Coordinating Investigator of the ‘Stress Ulcer Prophylaxis in the Intensive Care unit’ (SUP-ICU) trial. He is a passionate young clinical researcher and his PhD deals with different aspects of ulcer prophylaxis in critically ill patients.
He graduated from the Medical School of Copenhagen University in 2014 and he is an anesthesiologist intensivist in progress. Before beginning his PhD studies he was deployed as a physician with the Danish Army.
Prof. Anders Perner is an intensivist and clinical researcher in Copenhagen. His focus is on clinical research in critically ill patients; thus, he chairs the Danish national Centre for Research in Intensive Care and the Scandinavian Critical Care Trials Group. He chaired the two land-mark trials, the 6S and the TRISS trial, the results of which have improved fluid and transfusion therapy of patients with sepsis. His research continues along this track testing frequent interventions given to critically ill patient for which there are doubts about the balance between benefit and harm. The ongoing clinical research programs include the CLASSIC, SUP-ICU, AID-ICU, HOT-ICU, VITRACE and AFIB-ICU trial programs.